Supply of Avelumab for Medical Use
This public procurement contract involves the ongoing supply of medicinal products containing the active ingredient Avelumab, specifically in a concentration of 20 MG/ML. The products will be provided in 10 ML vials as an infusion solution. Deliveries will be made based on individual orders accordin
ClosedHealthcare & MedicalCzech RepublicPublished 18 Dec 2025